In patients on anti-tumor necrosis factor (TNF) medications, the disease presents as extrapulmonary or disseminated in 25-48% of cases [17], with central nervous system involvement still being rare, primarily manifesting as meningitis [17-19]. The gene discussed is TNF; the disease is meningitis.